Delivery Order SPE2DB22D3016-SPE2DB25FATD9
Award Date
4/4/25
Potential Completion Date
4/7/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,921.15 firm fixed-price contract is for the supply of the medication Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,572.11, is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug...
This federal contract award, valued at $2,764.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, which is a delivery order contract, covers the supply of the medication Mounjaro 15 mg/0.5 ml pen with a performance period through April 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,172.17, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 15 mg/0.5 ml pen (0.5 ml) with a ceiling value of $5,441.80. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award, valued at $3,945.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 15 mg/0.5 ml pen, a 0.5 ml pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of July 26, 2024. This award is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro 5 mg/0.5 ml pen. The award, valued at $3,156.00, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro (5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $3,209.65 and an ultimate completion date of October 10, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen, with a total ceiling value of $5,226.89 and a period of performance through November 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...